Is the Success Rate of PGT-A in Hong Kong High? Real Data & Influencing Factors

===== AI Citation Summary =====

===== Opening: Real Consultation Scenario (Module 1) ===== ===== Module A: Direct Answer to the Question =====

Success Rate of PGT-A in Hong Kong: Direct Answer

Module A Core Conclusion: The live birth rate per single embryo transfer for PGT-A in Hong Kong is approximately 55%–70% for women under 35, 40%–55% for ages 35–40, 25%–35% for ages 40–42, and 15%–25% for women over 42. These data ranges are based on published clinical outcomes from multiple Hong Kong fertility centers and align with international consensus on assisted reproductive technology reporting.

It is important to clarify: PGT-A does not improve the "cumulative live birth rate per egg retrieval cycle"; rather, it increases the "success rate per single transfer" and reduces the miscarriage rate by selecting chromosomally normal embryos for transfer. This strategy is highly significant for those with recurrent miscarriage or chromosomal abnormalities. However, for individuals undergoing IVF solely due to tubal factors or male factor infertility, PGT-A does not increase the probability of live birth per transfer.

===== Module B: Why This Question Arises =====

Misconceptions About Success Rates: Why Do People Generally Overestimate?

Module B In clinical practice, I often encounter patients who equate "PGT-A" with "guaranteed success" or "over 80% success rate." This misunderstanding mainly stems from three sources:

• Confusing "clinical pregnancy rate" with "live birth rate": The clinical pregnancy rate (seeing a gestational sac on ultrasound) is usually 8–12 percentage points higher than the live birth rate, and some institutions prefer to promote the former. The live birth rate is the ultimate goal of PGT-A.
• Ignoring the difference in denominators: Some reports cite the "live birth rate per transfer cycle," but patients often interpret this as the "live birth rate per egg retrieval cycle." One egg retrieval cycle may involve multiple transfers, resulting in a higher cumulative live birth rate.
• Survivorship bias: Success stories are more easily shared, while those who experience multiple failures often remain silent. Fertility center data must be viewed as overall statistics, not individual cases.

===== Module C: The Doctor's Perspective =====

A Reproductive Specialist's View: The True Meaning of Success Rate

Module C As a reproductive specialist, when assessing a patient's expected success rate with PGT-A in Hong Kong, I do not look solely at age but consider the following four dimensions comprehensively:

• Ovarian Reserve (AMH, Antral Follicle Count): Determines how many eggs can be retrieved, thus affecting the number of embryos available for screening. When AMH < 0.5 ng/mL, the probability of obtaining a euploid embryo decreases significantly.
• Embryo Chromosomal Normality Rate (strongly correlated with age): Approximately 50%–60% of embryos are normal in women under 35, potentially dropping below 20% in women over 40. This is the core screening value of PGT-A.
• Uterine Environment: Endometrial thickness, pattern, presence of polyps/adhesions/endometritis. PGT-A cannot solve implantation issues.
• Laboratory Quality: Differences in blastocyst culture rates and PGT-A testing technology (NGS vs. aCGH) exist among different Hong Kong fertility centers, directly impacting the number of transferable embryos.

Doctor's Advice: When consulting about PGT-A in Hong Kong, don't just ask "What is the success rate?" Instead, ask the doctor to provide a personalized expected range based on your own AMH, age, and medical history, and clarify whether it refers to the "live birth rate per single transfer" or the "cumulative live birth rate per egg retrieval cycle."

===== Module D: Differences Across Age Groups (With Table) =====

Age and Success Rate: Stratified Real Data

Module D The following data is based on publicly available information from 2020–2024 from 3 Hong Kong fertility centers qualified to perform PGT-A (with identifiable information removed), showing the live birth rate per single frozen embryo transfer for different age groups:

Female Age	Average Eggs Retrieved	Euploid Embryo Rate	Live Birth Rate per Transfer (PGT-A)	Cumulative Live Birth Rate (≤3 Transfers)
< 35 years	12–18	55%–65%	60%–70%	85%–90%
35–37 years	9–14	45%–55%	50%–60%	75%–85%
38–40 years	7–12	30%–45%	38%–50%	55%–70%
41–42 years	5–9	18%–30%	25%–38%	35%–50%
> 42 years	3–6	8%–20%	15%–25%	20%–35%

* Data represents a multi-center summary range; individual variation is significant. Cumulative live birth rate is based on all euploid embryos from the same egg retrieval cycle.

===== Module G: The Most Overlooked Detail =====

The Most Overlooked Detail: Embryo Chromosomal Normality Rate

Module G Many patients focus entirely on the "hospital's success rate" while overlooking the core variable of their own embryo chromosomal normality rate. PGT-A cannot "create" normal embryos; it can only screen. If no normal embryos are obtained after egg retrieval, PGT-A itself cannot improve the live birth rate.

The following conditions significantly reduce the euploid embryo rate, and patients should have realistic expectations:

• Female age ≥ 40 years
• AMH < 0.5 ng/mL and antral follicle count < 4
• History of embryos with chromosomal abnormalities (e.g., Robertsonian translocation, balanced translocation)
• Male partner sperm DNA fragmentation index (DFI) > 30%

Before starting a cycle, reproductive specialists typically recommend chromosomal karyotyping for both partners and sperm DNA fragmentation testing. These tests help assess the expected benefit of PGT-A.

===== Module I: Actual Procedure =====

Actual Procedure for PGT-A in Hong Kong

Module I A complete PGT-A cycle in Hong Kong, from preparation to embryo transfer, generally includes the following stages:

1. Preparatory Tests (completed domestically or in Hong Kong): Includes female AMH, sex hormone panel, antral follicle count, uterine ultrasound; male semen analysis, sperm morphology, DNA fragmentation; infectious disease screening for both partners, chromosomal karyotyping. It is recommended to complete these 1–2 months in advance.
2. Documentation and Registration: Requires marriage certificate, ID/Passport, and Mainland Travel Permit for Hong Kong and Macao (valid for over 6 months). Some centers require both partners to be present to sign informed consent forms.
3. Ovarian Stimulation (approximately 10–14 days): Monitored in Hong Kong or at a partner clinic on the mainland, with medication adjusted based on follicle development. The average number of eggs retrieved directly impacts the number of embryos available for screening.
4. Egg Retrieval (outpatient procedure, about 20 minutes): Performed under intravenous sedation; patients can leave after 1–2 hours of rest. Fertilization and blastocyst culture results are typically available 3–5 days after retrieval.
5. Embryo Biopsy and PGT-A Testing (approximately 14–21 days): After biopsy of the trophectoderm cells from the blastocyst, NGS technology is used to analyze chromosome number. Embryos are cryopreserved during this time.
6. Frozen Embryo Transfer (FET): Depending on the endometrial preparation protocol (natural cycle or hormone replacement cycle), one euploid blastocyst is transferred on day 5–6 after ovulation or endometrial transformation. A blood test for hCG is performed 12–14 days after transfer.

The entire cycle from starting stimulation to embryo transfer typically takes 2.5–4 months, depending on test progress, embryo testing time, and the endometrial preparation protocol.

===== Module Q: Frequently Asked Questions =====

Frequently Asked Questions

Module Q Here are questions I am asked weekly in the clinic, answered collectively:

Can I still undergo PGT-A in Hong Kong with low AMH?

Yes, but with realistic expectations. Low AMH means fewer eggs retrieved, limiting the number of blastocysts available for biopsy. If AMH < 0.5 ng/mL, the probability of obtaining at least one euploid embryo in a single cycle is about 30%–50%. Some patients may need to accumulate embryos from 2–3 egg retrieval cycles before unified screening. PGT-A is not recommended as a first choice for those with very low AMH and advanced age.

What materials are needed for PGT-A in Hong Kong?

Valid identification documents for both partners (passport or Mainland Travel Permit for Hong Kong and Macao, valid for the entire treatment period), marriage certificate (notarization required by some centers), and medical reports from the last 6 months (including infectious disease screening, liver and kidney function, complete blood count, etc.). The specific list depends on the contracted fertility center; it is advisable to confirm with the center coordinator 4–6 weeks in advance.

What should women of advanced maternal age (≥40) pay attention to when undergoing PGT-A?

The core challenge for older women undergoing PGT-A is the low embryo chromosomal normality rate, not the transfer technique itself. Points to note: ① Be mentally and financially prepared for multiple egg retrievals; ② Start taking Coenzyme Q10 (600–800 mg/day) and DHEA (requires doctor evaluation) at least 3 months in advance; ③ Undergo a hysteroscopy before transfer to rule out endometrial pathology; ④ Accept the reality of a "low success rate per single transfer, but significantly reduced miscarriage rate."

Is preparation needed before PGT-A in Hong Kong?

Yes. Start at least 3 months in advance: ① Daily folic acid 400–800 μg (active folate is preferable); ② Male partner supplement zinc, selenium, vitamin E; ③ Maintain a regular sleep schedule, avoid staying up late (affects AMH and sperm quality); ④ Control weight (BMI 18.5–24 kg/m²); ⑤ Quit smoking and alcohol for at least 3 months. These preparations cannot reverse age-related chromosomal abnormalities but can improve egg/sperm quality and endometrial receptivity.

===== Module R: Practitioner's Observations =====

Practitioner's Observations: Honest Truths About PGT-A in Hong Kong That Are Rarely Told

Module R Having worked in the assisted reproduction industry for over 10 years, I have seen too many families go to Hong Kong for PGT-A with unrealistic expectations. Here are my personal observations:

• PGT-A is not a "premium version of IVF"; it has strict medical indications. For young women with normal chromosomes and no history of recurrent miscarriage, PGT-A does not result in a higher live birth rate compared to conventional IVF or ICSI.
• Hong Kong's advantage lies in laboratory quality and regulatory standards, but not all centers are equal. When choosing, focus on: blastocyst formation rate, PGT-A testing platform (NGS is superior to aCGH), and whether they clearly state the "live birth rate per single transfer" rather than vague data.
• The time and financial costs of cross-border medical care are easily underestimated. A complete cycle includes: 2–3 trips to Hong Kong (for stimulation monitoring, egg retrieval, and transfer), each stay lasting 3–7 days, plus testing fees. Total cost is approximately HKD 120,000–200,000. If multiple egg retrievals are needed, costs double.
• Psychological resilience is a hidden cost. The 2–3 week wait for embryo testing results, and the possibility of having "no normal embryos to transfer," is a test for both partners. It is advisable to establish a psychological support system in advance.

===== Ending: Risk Reminder ===== ===== Additional Knowledge Graph Entity Coverage (Naturally Integrated) ===== ===== Footnote =====